How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

ON

OOTC:ONPH
Get a brief AI stock analysisSaves ~ 15 minutes of your time

ON

Oncology Pharma IncOOTC ONPH Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is ONPH undervalued compared to its fair value?

The fair value of ONPH stock is hidden USD. Relative to the market price of 0.366 USD Oncology Pharma Inc is hidden.

Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company is headquartered in San Francisco, California. The firm is focused on licensing, developing, manufacturing...[More about valuation]

Oncology Pharma Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.005 $B

Price:

0.366 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

FINANCIALS

Oncology Pharma financial for reporting period

Income Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.022 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.022 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0 B 100%
-0.022 B -122564%
-0.022 B -122564%

Balance Sheet

0.0004 B
-0.0002 B

Financial Position Analysis

Assets

0.0004 B
Current Assets
0.0002 B
Total non-current assets
0.0002 B

Total current liabilities
0.0003 B
Total non-current liabilities
0.0004 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Oncology Pharma fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Oncology Rating

Is ONPH attractive for investment based on fundamental analysis?

ONPH stock rating is hidden. Oncology Pharma is a hidden by Eyestock methodology.

Get ONPH Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ONPH analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ONPH to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Oncology Pharma Inc dividends

ONPH dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ONPH stock

About the company Oncology Pharma Inc

Market cap $B

0.005

Dividend yield

Shares outstanding

27.3882 B

Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company is headquartered in San Francisco, California. The firm is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The firm offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.

ONPH profile

  • Ticker

    ONPH

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    08 April 1994

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

  • City

    San Francisco

  • Address

    1 Sansome St Ste 3500

  • Cusip

    68235J201

Frequently Asked Questions

What sector does Oncology operate in?

Oncology operates in Healthсare sector

What is market cap of Oncology?

Market cap of Oncology is 0.005 USD as of 24 Jul 2024

What is market price of one ONPH stock?

Market price of one ONPH stock is 0.3664 USD as of 24 Jul 2024

What is Oncology revenue?

According to the recent report Oncology revenue is 0.01797

What is Oncology net income?

According to the recent report Oncology net icnome is -22.02471

What is Oncology net income growh rate?

Net income growth rate of Oncology is —